| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 39.39× | 39.39× | 40.60× | 35.83× | 51.17× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.89× | 1.82× | 2.14× | 3.34× | 3.59× | ||
| 0.24× | 0.24× | 0.25× | 0.29× | 0.22× | ||
| −0.19× | −0.19× | 1.46× | 0.83× | 4.35× | ||
| −0.10× | −0.10× | 0.70× | 0.28× | 1.13× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 51.17 | 35.83 | 40.60 | 39.39 | 39.39 | |
| Working Capital Turnover | 3.59 | 3.34 | 2.14 | 1.82 | 1.89 | |
| Asset Turnover | 0.22 | 0.29 | 0.25 | 0.24 | 0.24 | |
| Cash Conversion (CFO/Net Income) | 4.35 | 0.83 | 1.46 | -0.19 | -0.19 | |
| CFO/EBITDA | 1.13 | 0.28 | 0.70 | -0.10 | -0.10 |